Today in our editorial series – Towards 3% R&D – Turbocharging Australia’s Innovation Effort – we turn to the role of national industry policy. Here Roy Green points to innovation and the success of a Future Made in Australia as intertwined. While lacking detail at this stage, the significance of Prime Minister Albanese’s Future Made…
Drug development company IDT Australia and pharmaceutical business Sanofi have signed an agreement for the good manufacturing practice (cGMP) manufacture of Sanofi’s mRNA vaccines now under development. The partners will collaborate to advance mRNA-based vaccine formulation, development and manufacture at IDT’s aseptic sterile injectables filling facilities in Melbourne (pictured) in volumes needed for clinical trials…
Rio Tinto spends up big with local suppliers Rio Tinto increased its spend with suppliers and local businesses in Australia to more than $16.1 billion in 2023, as part of the company’s commitment to support communities where it operates. This was an increase of five per cent on the previous year and was spent with…
Microbial development and contract manufacturing companies Adelaide’s BioCina and Perth’s NovaCina have announced a strategic partnership to provide integrated drug substance and drug product solutions for the pharmaceutical sector. The two companies are buy-outs from the Pfizer pharmaceutical company and share the same investor – private investment firm Bridgewest Group – and will now collaborate…
Work has begun on a new $100 million pharmaceutical plant being built for Noumed Pharmaceutical at Salisbury in northern Adelaide in partnership with Terre Property Partners. The plant, supported by $20 million from the federal government’s Modern Manufacturing Strategy, is UK group Noumed Life Sciences’s first production plant in Australia. Noumed is an integrated generics…
Biotechnology giant CSL has reported net profit after tax for the six months ended December 31 of $1.9 billion, up 20 percent on the previous corresponding period. Underlying net profit was $2.02, set on revenue up 11 percent to $8.05 billion. CSL CEO and Managing Director Dr Paul McKenzie said: “Our strong first half result…
Private investment firm, Bridgewest Group has expanded its pharmaceuticals portfolio, announcing the purchase of the sterile injectable manufacturing facility of Pfizer (Perth) Pty Ltd, a subsidiary of Pfizer, Inc. The cGMP manufacturing facility, located in Bentley, Perth is a diverse sterile injectable manufacturing facility, approved to supply drug products in over 90 countries with approvals…
Healthcare manufacturer Viatris Australia has announced the Australian Made, Australian Grown (AMAG) logo has now been added to 50 of its Australian medicine products. In what the company describes as a first for a prescription medicine manufacturer in Australia, 50 products manufactured in Carole Park, Queensland, now showcase the logo. Products bearing the AMAG logo…
WA funds Fugro SpAARC to get into space The Western Australian government has announced a $5 million commitment to Perth-based facility Fugro SpAARC to bolster the complex’s operational capability for space missions. The government said in a statement the funding would pave the way for Fugro SpAARC to support international space missions from Perth. “It…
Austin powers ahead on benefits from revamped manufacturing Perth mining equipment manufacturer Austin Engineering has reported an EBITDA of $31 million for FY23 on revenue up 27 percent on the previous year to $258 million. Operating cash flow for the year was $15.8 million, up 236 percent, with the company ending the year with an…
